Safety evaluation of tarlatamab: A pharmacovigilance study based on the FAERS database
{{output}}
Objectives: Tarlatamab (Imdelltra, AMG757) has been approved for extensive-stage small cell lung cancer (ES-SCLC) treatment, yet post-marketing data remain limited. Existing studies lack conclusive evidence on its real-world safe... ...
